Xoft Revenue and Competitors
Estimated Revenue & Valuation
- Xoft's estimated annual revenue is currently $7.9M per year.
- Xoft's estimated revenue per employee is $125,500
- Xoft's total funding is $130.7M.
Employee Data
- Xoft has 63 Employees.
- Xoft grew their employee count by -7% last year.
Xoft's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. Director, X-ray Technologies | Reveal Email/Phone |
2 | Field Service Engineer | Reveal Email/Phone |
3 | Physicist - Clinical Applications and Support | Reveal Email/Phone |
4 | Systems Engineer | Reveal Email/Phone |
Xoft Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Xoft?
Founded in 1998, Xoft develops leading-edge technologies for the practice of radiation oncology through Electronic Brachytherapy, which utilizes proprietary miniaturized X-ray tube technology. The Axxent® Electronic Brachytherapy System, Xoft\'s first treatment system, is currently being used in Accelerated Partial Breast Irradiation (APBI) for the treatment of early-stage breast cancer and in the treatment of endometrial cancer.
keywords:N/A
$130.7M
Total Funding
63
Number of Employees
$7.9M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xoft News
... Analysis & Outlook to 2029 || Accuray Incorporated, IBA Worldwide, Eckert & Zeigler BEBIG, Xoft, a subsidiary of iCAD, Inc.
The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin...
Multiple leading institutions leverage the versatility of Xoft electronic brachytherapy (eBx) to increasingly treat multiple cancers.
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 63 | 29% | $61.6M |
#2 | $8.2M | 63 | -11% | N/A |
#3 | $16.4M | 63 | -10% | N/A |
#4 | $15.6M | 63 | 7% | N/A |
#5 | $8.2M | 63 | 2% | N/A |